•Downregulation of SOCS1 (Gorgun et al., 2010) •Increased cytotoxicity toward MM and K562 tumor cells (Davies et al., 2001; Payvandi et al., 2005). This evidence concerns the gene SOCS1 and Miyoshi myopathy.